The Global Analgesics Market is estimated to be USD 17.86 Bn in 2021 and is expected to reach USD 27.73 Bn by 2026, growing at a CAGR of 9.2%.
Market Dynamics
The major factor driving the growth of the global analgesics market are increased risk of heart disease, cancer, arthritis, chronic pain, and the aches and pains that the elderly population suffers from. Furthermore, advancements in treatment choices and the availability of well-established healthcare facilities are propelling the analgesics market demand. In addition, the discovery of novel medicines, growing awareness of these therapeutic alternatives, investment in research and developments by key players have supported the analgesics market and creating more opportunities for market growth.
However, uncontrolled opioid prescriptions, drug misuse, and strict regulation and policy by the government restrain the market and create challenges for the global analgesics market growth.
Market Segmentation
The Global Analgesics Market is segmented further based on Drug Type, Drug Class, Pain Type, Route of Administration, Distribution Channel, Application, and Geography.
By Drug Type, the market is classified into prescription, and over the counter (OTC), and others. Amongst all, the prescription segment is estimated to hold the highest market share during the forecast period.
By Drug Class, the market is classified as opioids, NSAID, and others. Amongst all, the Opioids segment is estimated to hold the highest market share during the forecast period.
By Pain Type, the market is classified as musculoskeletal, surgical and trauma, cancer, neuropathic, migraine, dental/facial, and others. Amongst all, the musculoskeletal segment is estimated to hold the highest market share during the forecast period.
By Route of Administration, the market is classified as oral, intravenous, rectal, transdermal, and topical. Amongst all, the oral segment is estimated to hold the highest market share during the forecast period.
By Distribution Channel, the market is classified as hospital pharmacies, retail pharmacies, drug stores. Amongst all, the hospital pharmacies segment is estimated to hold the highest market share during the forecast period.
By Application, the market is classified as internal analgesics and external analgesics. Amongst all, the internal analgesics segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Hikma Pharmaceuticals PLC announced a non-binding term sheet with GlaxoSmithKline PLC (GSK) to potentially acquire GSK’s pharmaceutical and consumer businesses in Egypt and its pharmaceutical business in Tunisia. - 26th January 2021
2. Pacira to Acquire Myoscience, adding Fda-Approved Iovera System for Non-Opioid Pain Control. - 5th March 2019
Company Profiles
Some of the companies covered in this report are 7T Pharma LLC, Abbott Laboratories, AbbVie Inc, Amphastar Pharmaceuticals, Inc, Aspen Pharmacare Holdings Limited, AstraZeneca PLC etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
Report Highlights:
Market Dynamics
The major factor driving the growth of the global analgesics market are increased risk of heart disease, cancer, arthritis, chronic pain, and the aches and pains that the elderly population suffers from. Furthermore, advancements in treatment choices and the availability of well-established healthcare facilities are propelling the analgesics market demand. In addition, the discovery of novel medicines, growing awareness of these therapeutic alternatives, investment in research and developments by key players have supported the analgesics market and creating more opportunities for market growth.
However, uncontrolled opioid prescriptions, drug misuse, and strict regulation and policy by the government restrain the market and create challenges for the global analgesics market growth.
Market Segmentation
The Global Analgesics Market is segmented further based on Drug Type, Drug Class, Pain Type, Route of Administration, Distribution Channel, Application, and Geography.
By Drug Type, the market is classified into prescription, and over the counter (OTC), and others. Amongst all, the prescription segment is estimated to hold the highest market share during the forecast period.
By Drug Class, the market is classified as opioids, NSAID, and others. Amongst all, the Opioids segment is estimated to hold the highest market share during the forecast period.
By Pain Type, the market is classified as musculoskeletal, surgical and trauma, cancer, neuropathic, migraine, dental/facial, and others. Amongst all, the musculoskeletal segment is estimated to hold the highest market share during the forecast period.
By Route of Administration, the market is classified as oral, intravenous, rectal, transdermal, and topical. Amongst all, the oral segment is estimated to hold the highest market share during the forecast period.
By Distribution Channel, the market is classified as hospital pharmacies, retail pharmacies, drug stores. Amongst all, the hospital pharmacies segment is estimated to hold the highest market share during the forecast period.
By Application, the market is classified as internal analgesics and external analgesics. Amongst all, the internal analgesics segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Hikma Pharmaceuticals PLC announced a non-binding term sheet with GlaxoSmithKline PLC (GSK) to potentially acquire GSK’s pharmaceutical and consumer businesses in Egypt and its pharmaceutical business in Tunisia. - 26th January 2021
2. Pacira to Acquire Myoscience, adding Fda-Approved Iovera System for Non-Opioid Pain Control. - 5th March 2019
Company Profiles
Some of the companies covered in this report are 7T Pharma LLC, Abbott Laboratories, AbbVie Inc, Amphastar Pharmaceuticals, Inc, Aspen Pharmacare Holdings Limited, AstraZeneca PLC etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Analgesics Market . The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Analgesics Market
What is the estimated value of the Global Analgesics Market?
What is the growth rate of the Global Analgesics Market?
What is the forecasted size of the Global Analgesics Market?
Who are the key companies in the Global Analgesics Market?
Report Attribute | Details |
---|---|
No. of Pages | 215 |
Published | May 2021 |
Forecast Period | 2021 - 2026 |
Estimated Market Value ( USD
| USD 17860 Million |
Forecasted Market Value ( USD
| USD 27730 Million |
Compound Annual Growth Rate | 9.2% |
Regions Covered | Global |
No. of Companies Mentioned | 30 |
Table of Contents
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Analgesics Market, By Drug Type
7 Global Analgesics Market, By Drug Class
8 Global Analgesics Market, By Pain Type
9 Global Analgesics Market, By Route of Administration
10 Global Analgesics Market, By Distribution Channel
11 Global Analgesics Market, By Application
12 Global Analgesics Market, By Geography
13 Competitive Landscape
14 Company Profiles
15 Appendix
Companies Mentioned
- 7T Pharma LLC
- Abbott Laboratories
- AbbVie Inc
- Amphastar Pharmaceuticals, Inc
- Aspen Pharmacare Holdings Limited
- Astrazeneca PLC
- Avir Pharma Inc
- B. Braun Melsungen AG
- Baxter International Inc
- Boehringer Ingelheim International GmbH
- Braun Melsungen AG
- Cantrell Drug Company
- Cipher Pharmaceuticals Inc
- Cipla USA Inc
- Claris Life sciences
- Eisai Co. Ltd
- Exelan Pharmaceuticals, Inc
- F. Hoffmann-La Roche Ltd
- Fresenius Kabi USA, LLC
- Glenmark Pharmaceuticals Limited
- Hikma Pharmaceuticals PLC
- Hospira, Inc
- Leucadia Pharmaceuticals
- Maruishi Pharmaceutical Co., Ltd.
- Mylan Institutional LLC
- Pacira Pharmaceuticals, Inc
- Paion UK Ltd
- Pfizer Inc
- Piramal Enterprises LTD
- Remedy Repack